Recent technological advances facilitate the reconstruction of complete brain connectomes in small organisms and partial connectomes in mammals, involving the mapping of the network of neurons and ...
This three-part series reviews how the Food and Drug Administration’s (FDA) January 2026 guidance, “General Wellness: Policy for Low Risk Devices”[1] (the General Wellness Guidance), affects companies ...
By adopting private equity firms' approach to optimizing talent, operating companies can make smarter, faster decisions to improve performance.
Global Survey Reveals that 65% of Senior Leaders See HR as a Key Business Enabler, Yet 51% Cite Administrative Load as Primary Barrier to Strategic Contribution.
A new column examines how premium airline capacity can help identify the most promising business aviation corridors from the ...
Western Pennsylvania healthcare innovators are working to improve patient safety. Their efforts help deepen Pittsburgh’s standing as a global safety center — and bring critical research and innovation ...
Georgia’s strategic location at the crossroads of Europe and Asia has long positioned the country as a key transit hub ...
Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the fourth quarter and full year of 2025.
Delays in high-profile investigations are fuelling concerns about the watchdog agency's ability to deliver timely outcomes - with some athletes walking away from their sports.
Longeveron Inc. (NASDAQ:LGVN) Q4 2025 Earnings Call Transcript March 17, 2026 Longeveron Inc. beats earnings expectations.
As digital marketplaces expand and consumer access increases, the way counterfeit products are encountered, evaluated, and purchased has evolved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results